A murine, myc-driven lymphoma model expressing human CD22 enables testing of targeted therapies and their effects on tumor immune microenvironment

Gsottberger F, Brandl C, Petkovic S, Emmerich C, Nitschke L, Mackensen A, Müller F (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 191-191

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

DOI: 10.1136/jitc-2020-itoc7.58

Authors with CRIS profile

Franziska Gsottberger Department of Medicine 5 – Haematology and Oncology Carolin Brandl Professur für Genetik Lars Nitschke Professur für Genetik Andreas Mackensen Lehrstuhl für Innere Medizin V Fabian Müller Department of Medicine 5 – Haematology and Oncology

How to cite

APA:

Gsottberger, F., Brandl, C., Petkovic, S., Emmerich, C., Nitschke, L., Mackensen, A., & Müller, F. (2020). A murine, myc-driven lymphoma model expressing human CD22 enables testing of targeted therapies and their effects on tumor immune microenvironment. In ONCOLOGY RESEARCH AND TREATMENT (pp. 191-191). BASEL: KARGER.

MLA:

Gsottberger, Franziska, et al. "A murine, myc-driven lymphoma model expressing human CD22 enables testing of targeted therapies and their effects on tumor immune microenvironment." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2020. 191-191.

BibTeX: Download